Serum MicroRNAs 223 and 146a in Allergic Rhinitis Patients as Biomarkers for Efficacy of Sublingual Immunotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The aim of the study is: * to evaluate the serum levels of miR-223 and miRNA146a and to assess their correlation with disease severity in allergic rhinitis patients and their role as biomarkers for efficacy of sublingual immunotherapy. * also to find if high sensitivity CRP can be an easy non-expensive test for diagnosis and follow up of allergic rhinitis patients.
Epistemonikos ID: d164a66a1583c0eb05ffc7db50514bd207f43a1c
First added on: May 08, 2024